KDM2B and neoplasm: Given that KDM2B delays cancer cell growth by inducing senescence and/or apoptosis, we sought to determine whether KDM2B could be inducing DNA damage in CRC cells, resulting in delayed cell growth and altering the regulation of its downstream proteins that are key to the survival and growth of tumor cells.